Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
8.21
-0.01 (-0.12%)
At close: Apr 9, 2026, 4:00 PM EDT
8.10
-0.11 (-1.34%)
After-hours: Apr 9, 2026, 4:43 PM EDT
Rallybio Market Cap
Rallybio has a market cap or net worth of $43.43 million as of April 9, 2026. Its market cap has increased by 58.22% in one year.
Market Cap
43.43M
Enterprise Value
-11.13M
1-Year Change
58.22%
Ranking
Category
Stock Price
$8.21
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $43.43M, a decrease of -89.29%. That is a compound annual growth rate of -37.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 43.43M | 49.84% |
| Dec 31, 2025 | 28.98M | -27.23% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
| Jul 29, 2021 | 405.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telomir Pharmaceuticals | 45.38M |
| Lisata Therapeutics | 45.16M |
| Immutep | 44.98M |
| Rein Therapeutics | 44.30M |
| Atossa Therapeutics | 42.02M |
| Lite Strategy | 41.09M |
| RenovoRx | 40.55M |
| Sensei Biotherapeutics | 40.46M |